Komori
General Meetings of Shareholders2395SHIN NIPPON BIOMEDICAL LABORATORIES,LTD.Information and Communications, Services and Others

Notice of Convocation of the 53rd Ordinary General Meeting of Shareholders

The 53rd Annual General Meeting of Shareholders will be held on 26 June 2026, with amendments to the Articles of Incorporation and the election of 14 directors to be submitted as agenda items. The number of directors is scheduled to increase by 2, from the current 12, resulting in a 14-director structure.

Worth reading
53Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
14
Number of director candidates
Wording
Definitive
How definitive the wording is.

Resolutions for the General Meeting of Shareholders

Annual, 53rd
2026
Jun 26
Date and time1:00 p.m. (doors open at 12:00 p.m.)22 days from this disclosure to the meeting
Matters for resolution2 items
  1. Partial amendments to the Articles of Incorporation

  2. Election of 14 directors

Shareholder Proposal

None (not specified)

A shareholder proposal is a resolution submitted by a shareholder, rather than by the company.
Director nominee
14Nominees
2New
6Outside
Resolutions for the General Meeting of Shareholders
ItemDetails
Type of shareholders' meetingAnnual, 53rd
Date and timeFriday, 26 June 2026, 1:00 p.m. (doors open at 12:00 p.m.)
Matters for resolutionProposal No. 1: Partial amendments to the Articles of Incorporation, Proposal No. 2: Election of 14 directors
Shareholder ProposalNone (not specified)
Director nominee14, including 2 new candidates and 6 outside directors
Items this document does not state (1)
Percentage voting in favor

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The amendments to the Articles of Incorporation are intended to further strengthen and enhance corporate governance and to provide greater flexibility for the future management structure. The increase in the number of directors is intended to strengthen the management structure.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Convocation of the 53rd Ordinary General Meeting of Shareholders | SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. (2395) timely disclosure | Komori